Bio-Path Holdings (BPTH)
NASDAQ:BPTH
Holding BPTH?
Track your performance easily

Bio-Path Holdings (BPTH) Financial Statements

398 Followers

Bio-Path Holdings Financial Overview

Bio-Path Holdings's market cap is currently ―. The company's EPS TTM is $-17.859; its P/E ratio is -0.05; Bio-Path Holdings is scheduled to report earnings on November 15, 2024, and the estimated EPS forecast is $-1.02. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -1.87M$ -3.69M$ -3.20M$ -4.23M$ -5.27M
EBITDA$ -1.79M$ -3.65M$ -3.15M$ -4.19M$ -5.23M
Net Income Common Stockholders$ -1.87M$ -3.16M$ -3.20M$ -4.23M$ -5.27M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 4.00M$ 200.00K$ 2.40M$ 3.40M$ 6.70M
Total Assets$ 5.12M$ 1.77M$ 5.02M$ 6.48M$ 11.10M
Total Debt$ 55.00K$ 85.00K$ 141.00K$ 168.00K$ 195.00K
Net Debt$ -3.94M$ -115.00K$ -2.26M$ -3.23M$ -6.50M
Total Liabilities$ 3.83M$ 4.39M$ 2.50M$ 1.48M$ 2.00M
Stockholders Equity$ 1.30M$ -2.60M$ 2.50M$ 5.04M$ 9.11M
Cash Flow-
Free Cash Flow$ -4.27M$ -1.04M$ -21.80M$ -3.29M$ -3.65M
Operating Cash Flow$ -4.27M$ -1.04M$ -21.80M$ -3.29M$ -3.65M
Investing Cash Flow-----
Financing Cash Flow$ 7.22M$ 174.00K$ 1.69M--
Currency in USD

Bio-Path Holdings Earnings and Revenue History

Bio-Path Holdings Debt to Assets

Bio-Path Holdings Cash Flow

Bio-Path Holdings Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis